Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q1 2022 · 10-Q
Revenue$30.37M$30.37M+16.9% vs Q1 2021 Net Income-$168.00K-$168.00KN/M vs Q1 2021 EPS Diluted-$0.01-$0.01N/M vs Q1 2021 Gross Profit$6,958,000−0.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Operating Cash Flow-$3,222,000N/M Free Cash Flowderived-$3,593,000N/M Margins · derivedGross margin22.9%−4.0 pt vs Q1 2021
Operating margin-1.0%−4.6 pt vs Q1 2021
Net margin-0.6%−3.1 pt vs Q1 2021
ended Mar 31, 2022 · filed Apr 28, 2022 · 28 d after period end